{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T21:27:40Z","timestamp":1748294860234},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T00:00:00Z","timestamp":1584403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1007\/s00105-020-04575-6","type":"journal-article","created":{"date-parts":[[2020,3,17]],"date-time":"2020-03-17T13:02:47Z","timestamp":1584450167000},"page":"624-626","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pityriasis rubra pilaris"],"prefix":"10.1007","volume":"71","author":[{"given":"D.","family":"Kohn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Wetzig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,17]]},"reference":[{"issue":"4","key":"4575_CR1","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1001\/jamadermatol.2016.5384","volume":"153","author":"L Feldmeyer","year":"2017","unstructured":"Feldmeyer\u00a0L, Mylonas\u00a0A, Demeria\u00a0O, Mennella\u00a0A, Yawalkar\u00a0N, Laffitte\u00a0E, Hohl\u00a0D, Gilliet\u00a0M, Conrad\u00a0C (2017) Interleukion 23-helper t cell 17 axis as a\u00a0treatment target for pityriasis rubra pilaris. JAMA Dermatol 153(4):304\u2013308","journal-title":"JAMA Dermatol"},{"key":"4575_CR2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1159\/000488902","volume":"10","author":"K Hanfstingl","year":"2018","unstructured":"Hanfstingl\u00a0K, Pekar-Lukacs\u00a0A, Motz\u00a0R, Guenova\u00a0E, Hoetzenecker\u00a0W (2018) Successful treatment of pityriasis rubra pilaris with ixekizumab. Case Rep Dermatol 10:97\u2013100","journal-title":"Case Rep Dermatol"},{"key":"4575_CR3","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.jdcr.2018.05.006","volume":"4","author":"MD Heibel","year":"2018","unstructured":"Heibel\u00a0MD, Heibel\u00a0HD (2018) Successful treatment of type I pityriasis rubra pilaris with ixekizumab. JAAD Case Rep 4:774\u2013776","journal-title":"JAAD Case Rep"},{"key":"4575_CR4","unstructured":"(2017) Antipsoriatika: Neue Therapien im Vergleich. https:\/\/www.pharmazeutische-zeitung.de\/ausgabe-092017\/neue-therapien-im-vergleich\/. Zugegriffen: 15.08.2019"},{"key":"4575_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.13718","author":"C Kromer","year":"2019","unstructured":"Kromer\u00a0C, Sabat\u00a0R, Celis\u00a0D, M\u00f6ssner\u00a0R (2019) Systemische Therapien bei Pityriasis rubra pilaris: eine systematische \u00dcbersicht. JDDG. https:\/\/doi.org\/10.1111\/ddg.13718","journal-title":"JDDG"},{"key":"4575_CR6","first-page":"70","volume":"46","author":"T Matsuda","year":"2019","unstructured":"Matsuda\u00a0T, Yamazaki\u00a0F, Uedo-Hayakawa\u00a0I, Kambe\u00a0N, Okamoto\u00a0H (2019) Case of pityriasis rubra pilaris progresses to generalized erythroderma following blockade of interleukion-17A, but improved after blockade of interleukin-12\/23 p40. JDA 46:70\u201372","journal-title":"JDA"},{"key":"4575_CR7","first-page":"612","volume-title":"Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie","author":"K Reich","year":"2012","unstructured":"Reich\u00a0K, Mrowietz\u00a0U (2012) Erythemat\u00f6se, papulonod\u00f6se und erythematosquam\u00f6se Erkrankungen. In: Plewig\u00a0G, Landthaler\u00a0M, Burgdorf\u00a0WHC, Hertl\u00a0M, Ruzicka\u00a0T (Hrsg) Braun-Falco\u2019s Dermatologie, Venerologie und Allergologie. Springer, Berlin, S 612\u2013615"},{"key":"4575_CR8","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jdcr.2018.02.007","volume":"4","author":"T Wain","year":"2018","unstructured":"Wain\u00a0T, Choy\u00a0B, Satchell\u00a0AC, Woods\u00a0JA, Frew\u00a0JW (2018) Secukinumab in pityriasis rubra pilaris: a case series demonstrating variable response and the need for minimal clinical datasets. JAAD Case Rep 4:500\u2013505","journal-title":"JAAD Case Rep"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04575-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-020-04575-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-020-04575-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,17]],"date-time":"2021-03-17T01:00:46Z","timestamp":1615942846000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-020-04575-6"}},"subtitle":["Eine erfolgreiche Therapie mit Ixekizumab"],"short-title":[],"issued":{"date-parts":[[2020,3,17]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["4575"],"URL":"https:\/\/doi.org\/10.1007\/s00105-020-04575-6","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,17]]},"assertion":[{"value":"17 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"D.\u00a0Kohn und T.\u00a0Wetzig geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}